Irinotecan Lipid Complex Injection
73 interactions 335 cited referencesIrinotecan lipid complex is used in combination with other medications to treat pancreatic cancer that has spread to other parts of the body that has worsened after treatment with other chemotherapy medications. Irinotecan lipid complex is in a class of antineoplastic medications called topoisomerase I inhibitors. It w… Read the full Irinotecan Lipid Complex Injection drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Major
Irinotecan Lipid Complex Injection Relacorilant Lifyorli Increased CYP3A4 substrate exposure and an increased risk of CYP3A4-substrate-related adverse reactions Details Irinotecan Lipid Complex Injection Ribociclib Kisqali Increased irinotecan liposome exposure and an increased irinotecan liposome active metabolite exposure Details Irinotecan Lipid Complex Injection Rifabutin Mycobutin Reduced irinotecan exposure and reduced irinotecan active metabolite exposure Details Irinotecan Lipid Complex Injection Rifampin Rifadin Reduced irinotecan exposure and reduced irinotecan active metabolite exposure Details Irinotecan Lipid Complex Injection Rifapentine Priftin Reduced irinotecan exposure and reduced irinotecan active metabolite exposure Details Irinotecan Lipid Complex Injection Ritonavir Norvir Increased irinotecan liposome exposure and an increased irinotecan liposome active metabolite exposure Details Irinotecan Lipid Complex Injection Rotavirus Vaccine, Live An increased risk of infection by the live vaccine Details Irinotecan Lipid Complex Injection Saquinavir Increased irinotecan liposome exposure and an increased irinotecan liposome active metabolite exposure Details Irinotecan Lipid Complex Injection St John's Wort Reduced irinotecan exposure and reduced irinotecan active metabolite exposure Details Irinotecan Lipid Complex Injection Tazemetostat Tazverik Reduced CYP3A substrate exposure and reduced efficacy of CYP3A substrate Details Irinotecan Lipid Complex Injection Telaprevir Increased irinotecan liposome exposure and an increased irinotecan liposome active metabolite exposure Details Irinotecan Lipid Complex Injection Telithromycin Increased irinotecan liposome exposure and an increased irinotecan liposome active metabolite exposure Details Irinotecan Lipid Complex Injection Troleandomycin Increased irinotecan liposome exposure and an increased irinotecan liposome active metabolite exposure Details Irinotecan Lipid Complex Injection Tucatinib Tukysa Increased irinotecan liposome exposure and an increased irinotecan liposome active metabolite exposure Details Irinotecan Lipid Complex Injection Voriconazole Vfend Increased irinotecan liposome exposure and an increased irinotecan liposome active metabolite exposure DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist